Home / Sell by State / California / Los Angeles
Los Angeles · Sell-Side M&A
Los Angeles is the highest-demand aesthetics market in the country, and the consolidation wave is already here. In March 2024, a PE-backed platform acquired a nearly 30-year-old Beverly Hills and Santa Monica practice. That demand is real, and so is California's strict structure rule. We represent Los Angeles owners only, and we build the deal around the rules and the buyers who are actually closing here.
A confidential ballpark in under two minutes, no email required.
The State Rules, In Brief
California restricts the corporate practice of medicine more tightly than almost any other state, so a non-physician, a private equity firm, or a general corporation cannot own a medical practice or control clinical decisions in Los Angeles. The lawful path is the friendly-PC and MSO model: a physician-owned professional corporation keeps the clinical practice, and a separate management services organization, the part a non-physician investor owns and funds, provides non-clinical business services for a fee. The MSO is what gets bought and sold, which is why a Los Angeles sale is a structured transaction, never a simple stock sale. SB 351, effective January 1, 2026, also bars private equity groups and hedge funds from controlling clinical matters and bans non-compete and non-disparagement clauses in these management arrangements, so older agreements may need rework before close. AB 1415 expands premerger notice to California's Office of Health Care Affordability for larger deals. There is no Los Angeles County rule that overrides this. The same California law governs a deal in Beverly Hills, Santa Monica, or anywhere in the metro. That is the short version, focused on what matters for a Los Angeles deal. The full statutory anchors and the deeper compliance treatment live on our California state hub.
| Measure | Figure | Note |
|---|---|---|
| Med spas in California | ~1,150 | Second-largest by count |
| National rank by count | 2nd | Behind FL ~1,180 |
| Out of U.S. total | 10,488 | All U.S. med spas |
| LA positioning | #1 Botox | Highest-demand U.S. market |
No independently citable med-spa count exists for Los Angeles alone, because city directory scrapes count non-physician day spas and salons and far exceed the state cap, so density is framed at the verified state level. California counts roughly 1,150 medical spas, second nationally out of 10,488. Treat the figures as data-set estimates, not a state-certified statistic.
Market Reality
California counts roughly 1,150 medical spas in a data set drawing on AmSpa's 2024 State of the Medical Spa Industry report and US Census County Business Patterns, ranking it second nationally out of 10,488 med spas in the United States, behind Florida at roughly 1,180. Los Angeles is the demand epicenter of that market, ranked first nationally for Botox purchases in a Groupon study, with McKinsey data showing some LA practices draw 30 to 50 percent of clients from men. There is no honest metro-level count to quote, because the inflated city directory figures count non-medical spas, so we frame density at the state level and let the deal record speak: a PE-backed platform acquired a Beverly Hills and Santa Monica practice in March 2024. That is the consolidation demand a Los Angeles seller is sitting on.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No Los Angeles-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a Los Angeles seller's realized value is how the deal has to be built under California structure, and how much buyer competition the city's deep demand attracts. Demand can move you toward the top of the national range. It does not produce a separate Los Angeles number.
Because a California deal runs through a friendly-PC and MSO wrap, a buyer is paying for the MSO's management-fee stream and the durability of the PC relationship, not a clean equity purchase. A cleanly structured Los Angeles practice transacts faster and holds its multiple.
See the state rules →Los Angeles is the highest-demand aesthetics market in the country, ranked first nationally for Botox, with an unusually broad and affluent client base. That depth attracts more buyer competition for well-run practices, which supports the national range for a well-prepared seller.
Why LA demand matters →SB 351 forces management and employment agreements to be cleaned up before close, and AB 1415 notice can add time to larger California transactions, which buyers price in. Getting the structure right before market protects your price through diligence.
Map my structure →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a Los Angeles-specific multiple, because none exists in a citable, defensible form. In Los Angeles, value is moved more by structure, compliance readiness, and verified buyer competition than by a geographic multiple. Your real range comes from a confidential, practice-specific analysis of your earnings, your MSO structure, and your comps.
Who Is Actually Buying in Los Angeles
A Los Angeles seller is not waiting on hypothetical demand. In March 2024, MedSpa Partners, backed by Persistence Capital Partners, acquired Ava MD, the practice founded by Dr. Ava Shamban, adding two Los Angeles area clinics in Beverly Hills and Santa Monica. Ava MD had run for nearly 30 years before the deal, and both locations now sit on the MedSpa Partners partner directory. That is a named, public, in-market transaction inside Los Angeles, not a national press release that mentions the city in passing. It is the clearest signal that well-capitalized buyers are putting capital to work in the city's most affluent submarkets, and it sets the tone for what a Los Angeles owner can take to market.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential. MedSpa Partners and Persistence Capital Partners are the verified, in-market proof point, documented via a March 13, 2024 PR Newswire press release on the Ava MD acquisition, with both Beverly Hills and Santa Monica locations confirmed on the MedSpa Partners partner directory. The Botox demand-leadership figure is from a Groupon study cited by portraitcare.com. No local-only buyer is invented.
Los Angeles Sale FAQ
There is a documented, in-market proof point. In March 2024, MedSpa Partners, backed by Persistence Capital Partners, acquired Ava MD, the practice founded by Dr. Ava Shamban, adding two Los Angeles area clinics in Beverly Hills and Santa Monica. Ava MD had operated for nearly 30 years before the deal, and both locations are listed on the MedSpa Partners partner directory. That is a named, public, in-market transaction inside Los Angeles, not a national press release that mentions the city in passing. Beyond that named deal, well-capitalized national platforms and PE-backed MSOs treat Los Angeles as a priority market. We name MedSpa Partners and Persistence Capital Partners because the deal is public and verifiable, and we will never assert a local-only buyer that does not exist.
California is the second-largest med-spa state in the country, and Los Angeles is its demand epicenter. A Groupon study ranked Los Angeles first nationally for Botox purchases, which marks it as the highest-demand aesthetics market in the United States. McKinsey research has also found that some Los Angeles area practices draw 30 to 50 percent of their clientele from men, a far broader demographic reach than the female-skewed national average. For a buyer, an unusually broad and affluent local client base lowers concentration risk and supports durable demand, which is exactly the profile a consolidator pays up for. That demand depth, paired with California structure, is what a Los Angeles seller takes to market.
No. There is no published Los Angeles-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how California law and the Los Angeles market move structure and value. A practice that is already cleanly structured for compliance, with a defensible MSO agreement and no SB 351-offending clauses, transacts faster and holds its value. A practice that is not invites re-trading and discounts. Los Angeles demand depth supports the national range for a well-prepared seller, but it does not create a citable city multiple. Your real number comes from a confidential, practice-specific analysis.
California restricts the corporate practice of medicine, so a non-physician, a private equity firm, or a general corporation cannot own a medical practice or control clinical decisions in Los Angeles. The lawful path is the friendly-PC and MSO model: a physician-owned professional corporation keeps the clinical practice, and a separate management services organization, the part a non-physician investor owns and funds, contracts to provide non-clinical business services for a fee. The MSO is what gets bought and sold. SB 351, effective January 1, 2026, also bars private equity groups and hedge funds from controlling clinical matters and bans non-compete and non-disparagement clauses in these management arrangements. For the full statutory treatment, including AB 1415 premerger notice and the OHCA review process, see our California state hub. This page focuses on how those rules play out in the Los Angeles deal market.
California counts roughly 1,150 medical spas in a data set drawing on the American Med Spa Association 2024 State of the Medical Spa Industry report and US Census County Business Patterns, ranking it second nationally out of 10,488 med spas in the United States, behind Florida at roughly 1,180. Los Angeles is the demand epicenter of that market, ranked first nationally for Botox purchases in a Groupon study. There is no independently citable count of med spas for Los Angeles alone, because directory scrapes that report far higher city figures count non-physician day spas and salons rather than true medical spas, so we frame density at the verified state level and rely on the qualitative reality that Los Angeles is the highest-demand aesthetics market in the country. Treat the figures as data-set estimates, not a state-certified statistic.
Yes, unless and until you choose to tell people. We run every process under strict confidentiality, with confidentiality agreements, secure data rooms, staged disclosure, and a vetted buyer process. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position in a competitive Los Angeles market, so you decide what is shared, with whom, and when. Note that some larger California transactions can require advance notice to a state agency under AB 1415, and we plan for that openly with you as part of the structure.
Where To Go Next
The full corporate-practice-of-medicine treatment: the friendly-PC and MSO model, the 2026 SB 351 and AB 1415 reforms, and the statutory anchors that govern every California sale.
Read the California state hub →How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the Los Angeles demand and California structure work above.
Med spa sell-side →The valuation and deal-structure work for a surgical aesthetic practice, mapped to California's corporate-practice rules and the Los Angeles buyer market.
Plastic surgery sell-side →Why Los Angeles Commands Buyer Attention
California sets the structure rules, and the full statutory treatment lives on our California state hub. What makes Los Angeles different inside that state is demand. This is the single highest-demand aesthetics market in the country, with an unusually broad and affluent client base, and that depth is exactly what a consolidator underwrites when it decides where to buy.
A Groupon study ranked Los Angeles first nationally for Botox purchases. That is not a vanity stat. It signals the deepest injectable demand in the country, the high-frequency, high-margin treatment category that anchors most aesthetic practice cash flow.
McKinsey research has found that some Los Angeles area aesthetic practices draw 30 to 50 percent of their clientele from men, far above the female-skewed national average. A broader demographic means less concentration risk and a wider runway for the buyer to grow.
The Los Angeles client base is not only broad, it is affluent, which makes elective aesthetic spend more durable through cycles. Durable, recurring demand is what lets a buyer model a practice's cash flow with confidence and pay closer to the top of the range.
A market this deep and this broad reduces the perceived demand risk a buyer prices into any offer. Less risk for the buyer is a higher, more durable price for the seller. In Los Angeles, the local demand story is part of your negotiating position, and we put it to work for you.
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
